Alopecia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic prediction of male pattern baldness.
|
28196072 |
2017 |
Forced expiratory volume function
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry.
|
26634245 |
2015 |
Smoking
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
|
26053186 |
2015 |
Adolescent idiopathic scoliosis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease.
|
30019117 |
2018 |
Smoking Behaviors
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
|
26053186 |
2015 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease.
|
30019117 |
2018 |
Autosomal dominant compelling helio ophthalmic outburst syndrome
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |
Liver carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The variant genotypes of rs7763881 in HULC may contribute to decreased susceptibility to HCC in HBV persistent carriers.
|
22493738 |
2012 |
Liver carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pertinent to clinical practice, a genetic variant in the HULC gene has been found to alter the risk for hepatocellular carcinoma and oesophageal cancer, whereas cancer patients with high or low expression of HULC exhibit different clinical outcome.
|
27781386 |
2017 |
HYPOPLASTIC LEFT HEART SYNDROME 2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects.
|
28468790 |
2017 |
HYPOPLASTIC LEFT HEART SYNDROME 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects.
|
28468790 |
2017 |
Malignant Neoplasms
|
0.060 |
GeneticVariation
|
group |
BEFREE |
Genetic polymorphisms in lncRNA HULC may affect the susceptibility and clinical outcome of cancer.
|
29803923 |
2018 |
Primary malignant neoplasm
|
0.040 |
GeneticVariation
|
group |
BEFREE |
Genetic polymorphisms in lncRNA HULC may affect the susceptibility and clinical outcome of cancer.
|
29803923 |
2018 |
Colorectal Carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, rs6983267 and rs7763881 are potential genetic markers of CRC predisposition and correlate with serum CCAT2 and HULC, two novel potential non-invasive diagnostic biomarkers for CRC.
|
29176650 |
2017 |
Malignant neoplasm of esophagus
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer.
|
25874495 |
2015 |
Malignant neoplasm of esophagus
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Pertinent to clinical practice, a genetic variant in the HULC gene has been found to alter the risk for hepatocellular carcinoma and oesophageal cancer, whereas cancer patients with high or low expression of HULC exhibit different clinical outcome.
|
27781386 |
2017 |
Esophageal Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer.
|
25874495 |
2015 |
Esophageal carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer.
|
25874495 |
2015 |
Adenomatous Polyps
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Serum CCAT2 and HULC were upregulated in CRC and AP patients versus controls and discriminated these groups by ROC analysis. rs6983267 GG and rs7763881 AA patients demonstrated higher serum CCAT2 and HULC compared with GT/TT and AC, respectively. rs6983267 and serum HULC predicted CRC diagnosis among non-CRC groups (AP + controls) by multivariate analysis.
|
29176650 |
2017 |
Squamous cell carcinoma of esophagus
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have genotyped the ANRIL rs2151280 T/C, POLR2E rs3787016 C/T, and HULC rs7763881 A/C SNPs in 380 esophageal squamous cell carcinoma (ESCC) cases and 380 cancer-free controls.
|
25874495 |
2015 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients.
|
29176650 |
2017 |
Malignant neoplasm of liver
|
0.330 |
Biomarker
|
disease |
CTD_human |
The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.
|
28765279 |
2017 |
Malignant neoplasm of liver
|
0.330 |
Biomarker
|
disease |
BEFREE |
We aimed to investigate the association of HULC tagSNPs with the risk and prognosis of hepatocellular cancer, as well as the influence of the SNPs on lncRNA expression level.
|
29803923 |
2018 |
Malignant neoplasm of liver
|
0.330 |
Biomarker
|
disease |
BEFREE |
Moreover, HULC accelerates malignant progression of liver cancer cells in vitro and in vivo.
|
29895332 |
2018 |
Liver neoplasms
|
0.320 |
Biomarker
|
group |
CTD_human |
The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.
|
28765279 |
2017 |